1 unchanged sentence
Trading Plans of Our Directors and Officers
−Removed: During the quarter ended September 30, 2025 , none of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each item is defined in Item 408 of Regulation S-K.
−Removed: Departure of Principal Accounting Officer
−Removed: Klaskin, VP, Finance, Principal Financial Officer, Principal Accounting Officer of the Company, has informed the Company that after nearly 30 years with the Company she will be retiring effective December 31, 2025.
−Removed: Klaskin will continue as a consultant to the Company.
−Removed: Promissory Note Agreement by and between and Agenus Inc.
−Removed: and Zydus Pharmaceuticals (USA) Inc., dated October 8,2025.
−Removed: Filed herewith.
−Removed: Convertible Promissory Note Purchase Agreement by and between MiNK Therapeutics Inc.
−Removed: and Agenus Inc., dated February 12, 2024.
−Removed: Filed herewith.
−Removed: Form of Convertible Promissory Note by and between MiNK Therapeutics Inc.
−Removed: and Agenus Inc., dated February 12, 2024.
−Removed: Filed herewith.
−Removed: Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
−Removed: Filed herewith.
−Removed: Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
+Added: During the quarter ended March 31, 2026 , none of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each item is defined in Item 408 of Regulation S-K.
+Added: Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
Filed herewith.
9 unchanged sentences
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
−Removed: * Certain portions of this exhibit (indicated by “[***]”) have been omitted in compliance with Regulation S-K Item 601(b)(10)(iv) as the Company determined the omitted information (i) is not material and (ii) is the type that the Company customarily and actually treats as private or confidential.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 10, 2025
−Removed: /s/ CHRISTINE M.
−Removed: VP, Finance, Principal Financial Officer, Principal Accounting Officer
+Added: Chairman and Chief Executive Officer
+Added: (Principal Executive and Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.